Ivarsdottir E, Gudmundsson J, Tragante V, Sveinbjornsson G, Kristmundsdottir S, Stacey S
Nat Genet. 2024; 56(11):2422-2433.
PMID: 39472694
DOI: 10.1038/s41588-024-01966-6.
Mestrallet G, Brown M, Bozkus C, Bhardwaj N
Front Immunol. 2023; 14:1210164.
PMID: 37492581
PMC: 10363668.
DOI: 10.3389/fimmu.2023.1210164.
Boland C, Koi M, Hawn M, Carethers J, Yurgelun M
Dig Dis Sci. 2023; 68(9):3504-3513.
PMID: 37402979
PMC: 11262588.
DOI: 10.1007/s10620-023-08006-z.
Johansen E, Thusgaard C, Thomassen M, Boonen S, Jochumsen K
Gynecol Oncol Rep. 2022; 44:101105.
PMID: 36388756
PMC: 9664473.
DOI: 10.1016/j.gore.2022.101105.
Pudjihartono M, Perry J, Print C, OSullivan J, Schierding W
Clin Epigenetics. 2022; 14(1):120.
PMID: 36171609
PMC: 9520844.
DOI: 10.1186/s13148-022-01342-3.
Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy.
Dal Buono A, Gaiani F, Poliani L, Correale C, Laghi L
J Pers Med. 2021; 11(12).
PMID: 34945805
PMC: 8707096.
DOI: 10.3390/jpm11121333.
From APC to the genetics of hereditary and familial colon cancer syndromes.
Olkinuora A, Peltomaki P, Aaltonen L, Rajamaki K
Hum Mol Genet. 2021; 30(R2):R206-R224.
PMID: 34329396
PMC: 8490010.
DOI: 10.1093/hmg/ddab208.
Genome profiling of mismatch repair genes in eight types of tumors.
Wang S, Guan G, Zou C, Guo Q, Cheng W, Shen S
Cell Cycle. 2021; 20(11):1091-1106.
PMID: 33966609
PMC: 8208120.
DOI: 10.1080/15384101.2021.1922160.
Albert de la Chapelle (1933-2020).
Toland A, Hampel H
Am J Hum Genet. 2021; 108(2):214-216.
PMID: 33545027
PMC: 8175911.
DOI: 10.1016/j.ajhg.2021.01.004.
Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes-Considerations for Future Studies.
Te Paske I, Ligtenberg M, Hoogerbrugge N, de Voer R
Int J Mol Sci. 2020; 21(22).
PMID: 33228212
PMC: 7699508.
DOI: 10.3390/ijms21228757.
The role of genomics in global cancer prevention.
Ginsburg O, Ashton-Prolla P, Cantor A, Mariosa D, Brennan P
Nat Rev Clin Oncol. 2020; 18(2):116-128.
PMID: 32973296
DOI: 10.1038/s41571-020-0428-5.
P53 expression and micro-vessel density in relation with 5-year survival in patients with colorectal cancer.
Mohammed A, Arif S, Pity I
Ann Med Surg (Lond). 2020; 57:311-314.
PMID: 32874562
PMC: 7452034.
DOI: 10.1016/j.amsu.2020.08.006.
Mouse models of colorectal cancer: Past, present and future perspectives.
Burtin F, Mullins C, Linnebacher M
World J Gastroenterol. 2020; 26(13):1394-1426.
PMID: 32308343
PMC: 7152519.
DOI: 10.3748/wjg.v26.i13.1394.
Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome.
Abildgaard A, Stein A, Nielsen S, Schultz-Knudsen K, Papaleo E, Shrikhande A
Elife. 2019; 8.
PMID: 31697235
PMC: 6837844.
DOI: 10.7554/eLife.49138.
Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade.
Georgiadis A, Durham J, Keefer L, Bartlett B, Zielonka M, Murphy D
Clin Cancer Res. 2019; 25(23):7024-7034.
PMID: 31506389
PMC: 6892397.
DOI: 10.1158/1078-0432.CCR-19-1372.
[Hereditary colon cancer in Lynch syndrome/HNPCC syndrome in Germany].
Buttner R, Friedrichs N
Pathologe. 2019; 40(6):584-591.
PMID: 31372733
DOI: 10.1007/s00292-019-0643-y.
Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
Tamura K, Kaneda M, Futagawa M, Takeshita M, Kim S, Nakama M
Int J Clin Oncol. 2019; 24(9):999-1011.
PMID: 31273487
DOI: 10.1007/s10147-019-01494-y.
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy.
Zhao P, Li L, Jiang X, Li Q
J Hematol Oncol. 2019; 12(1):54.
PMID: 31151482
PMC: 6544911.
DOI: 10.1186/s13045-019-0738-1.
Linkage analysis revealed risk loci on 6p21 and 18p11.2-q11.2 in familial colon and rectal cancer, respectively.
von Holst S, Jiao X, Liu W, Kontham V, Thutkawkorapin J, Ringdahl J
Eur J Hum Genet. 2019; 27(8):1286-1295.
PMID: 30952955
PMC: 6777498.
DOI: 10.1038/s41431-019-0388-3.
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
Seppala T, Ahadova A, Dominguez-Valentin M, Macrae F, Evans D, Therkildsen C
Hered Cancer Clin Pract. 2019; 17:8.
PMID: 30858900
PMC: 6394091.
DOI: 10.1186/s13053-019-0106-8.